Category

Health System & Payment

Market access decides whether a product is paid for; this page covers how the system pays for care itself. It collects the regulatory updates HealthSignal tracks on hospital and provider payment systems, including prospective payment rules, diagnosis-related groups and tariffs, alongside facility licensing, care quality inspection regimes, service commissioning, and the regulation of health professionals. In the United States this is largely Medicare and Medicaid rulemaking from CMS; in Europe it is split across national payers and health ministries. Every item is drawn from official public bodies at the level of regulation, policy, and law.

Regulation Category Impact Date

New guidance: 'How to' KIM for care facilities

gematik publishes implementation guidance for KIM (secure messaging system) adoption in nursing and care facilities.

gematik (German Digital Health) · Germany
Digital Health & AIHealth System & Payment
Medium

Medicare and Medicaid Programs; CY 2027 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program

Proposed rule updating physician fee schedule, Part B payment policies, drug inflation rebate program, quality payment program, and promoting interoperability program for 2027.

US Federal Register - CMS Rules · United States
Health System & PaymentMarket Access & Reimbursement
High

Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients — effective date postponed to March 21, 2025

DEA and HHS postponed effective dates of final rules expanding buprenorphine telemedicine treatment and VA continuity-of-care telemedicine from February 18 to March 21, 2025, pending further policy review.

US Federal Register - DEA Telehealth Rules · United States
Digital Health & AIPharmaceuticalsHealth System & Payment
High

Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients — effective date delayed to March 21, 2025

DEA and HHS delayed the effective date of two final rules expanding buprenorphine telemedicine treatment and VA continuity of care via telemedicine from February 18 to March 21, 2025.

US Federal Register - DEA Telehealth Rules · United States
Digital Health & AIPharmaceuticalsHealth System & Payment
High

Expansion of Buprenorphine Treatment via Telemedicine Encounter

DEA and HHS amend regulations to permit practitioners to prescribe schedule III-V controlled substances for opioid use disorder via audio-only telemedicine, including initial six-month supplies after PDMP review.

US Federal Register - DEA Telehealth Rules · United States
Digital Health & AIPharmaceuticalsHealth System & Payment
High

Expansion of Induction of Buprenorphine via Telemedicine Encounter

DEA expands authorization for practitioners to prescribe schedule III-V narcotic drugs for maintenance and withdrawal management via telemedicine, including audio-only encounters.

US Federal Register - DEA Telehealth Rules · United States
Digital Health & AIPharmaceuticalsHealth System & Payment
High
Showing 29 of 29 tracked updates — health-tech relevant only. Show all health policy See all in the feed